CTLA4 and hematocrit: Together, 16 putative HT susceptibility loci have been identified; however, the most convincing evidence for associations is limited to HLA (6p21), CTLA4 (2q33.2), PTPN22 (1q13.2), and FOXE1 (9q22.33) variants.